Kenji Ina

3.0k total citations
103 papers, 2.4k citations indexed

About

Kenji Ina is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Kenji Ina has authored 103 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 29 papers in Surgery and 29 papers in Epidemiology. Recurrent topics in Kenji Ina's work include Inflammatory Bowel Disease (23 papers), Gastric Cancer Management and Outcomes (20 papers) and Helicobacter pylori-related gastroenterology studies (17 papers). Kenji Ina is often cited by papers focused on Inflammatory Bowel Disease (23 papers), Gastric Cancer Management and Outcomes (20 papers) and Helicobacter pylori-related gastroenterology studies (17 papers). Kenji Ina collaborates with scholars based in Japan, United States and United Kingdom. Kenji Ina's co-authors include Takafumi Ando, Kazuo Kusugami, Akira Imada, Takae Kataoka, Takeo Yamaguchi, Claudio Fiocchi, Masahiro Ohsuga, Masataka Shinoda, T Sakai and Hidemi Goto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Kenji Ina

98 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Ina Japan 25 866 637 621 520 436 103 2.4k
MF Neurath Germany 22 920 1.1× 637 1.0× 815 1.3× 479 0.9× 653 1.5× 72 2.6k
Norbert Lügering Germany 26 1.3k 1.5× 360 0.6× 609 1.0× 568 1.1× 548 1.3× 58 3.0k
Gail West United States 28 1.1k 1.2× 766 1.2× 1.2k 1.9× 415 0.8× 588 1.3× 65 3.0k
Hidetoshi Takedatsu Japan 25 1.3k 1.4× 390 0.6× 563 0.9× 364 0.7× 424 1.0× 83 2.4k
Yasuhiro Nemoto Japan 26 748 0.9× 414 0.6× 546 0.9× 668 1.3× 245 0.6× 59 2.4k
Jean Villard Switzerland 33 1.5k 1.7× 419 0.7× 277 0.4× 384 0.7× 608 1.4× 139 3.4k
W F Doe Australia 31 1.1k 1.3× 554 0.9× 814 1.3× 355 0.7× 660 1.5× 57 3.0k
Minoru Matsuura Japan 28 561 0.6× 751 1.2× 749 1.2× 250 0.5× 795 1.8× 143 2.5k
Daniele Fina Italy 27 1.8k 2.1× 549 0.9× 951 1.5× 486 0.9× 558 1.3× 44 3.0k
Eleonora Franzè Italy 27 1.0k 1.2× 307 0.5× 493 0.8× 591 1.1× 366 0.8× 62 2.3k

Countries citing papers authored by Kenji Ina

Since Specialization
Citations

This map shows the geographic impact of Kenji Ina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Ina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Ina more than expected).

Fields of papers citing papers by Kenji Ina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Ina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Ina. The network helps show where Kenji Ina may publish in the future.

Co-authorship network of co-authors of Kenji Ina

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Ina. A scholar is included among the top collaborators of Kenji Ina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Ina. Kenji Ina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ina, Kenji, et al.. (2017). Complete response of metastatic gastric cancer to chemoimmunotherapy. The Indian Journal of Medical Research. 146(1). 141–141. 5 indexed citations
2.
Iwamoto, Shigeyoshi, Tsuyoshi Takahashi, Hiroshi Tamagawa, et al.. (2015). FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study. Annals of Oncology. 26(7). 1427–1433. 43 indexed citations
3.
Yasui, Hirofumi, Kei Muro, Yasuhiro Shimada, et al.. (2014). A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study. Journal of Cancer Research and Clinical Oncology. 141(1). 153–160. 19 indexed citations
4.
Takeuchi, Yuuki, et al.. (2011). A case of metastatic skin tumor treated with Mohs' gauze methods using gauze applied with Mohs' paste. Palliative Care Research. 6(1). 324–329. 4 indexed citations
5.
Watanabe, Osamu, Takafumi Ando, Emad El‐Omar, et al.. (2009). Role of endoscopic ultrasonography in predicting the response to cyclosporin A in ulcerative colitis refractory to steroids. Digestive and Liver Disease. 41(10). 735–739. 13 indexed citations
6.
Shimada, Masaaki, Takafumi Ando, Richard M. Peek, et al.. (2008). Helicobacter pylori infection upregulates interleukin-18 production from gastric epithelial cells. European Journal of Gastroenterology & Hepatology. 20(12). 1144–1150. 32 indexed citations
7.
Ina, Kenji, Kazuo Kusugami, Yasushi Kawano, et al.. (2005). Intestinal Fibroblast-Derived IL-10 Increases Survival of Mucosal T Cells by Inhibiting Growth Factor Deprivation- and Fas-Mediated Apoptosis. The Journal of Immunology. 175(3). 2000–2009. 19 indexed citations
8.
Suzuki, Takefumi, Masafumi Ito, Akira Ishihara, et al.. (2003). Cytotoxic molecules expressed by intraepithelial lymphocytes may be involved in the pathogenesis of acute gastric mucosal lesions. Journal of Gastroenterology. 38(3). 216–221. 11 indexed citations
9.
Shimada, Muneaki, Kenji Ina, Kazuhiro Kyokane, et al.. (2002). Upregulation of Mucosal Soluble Fas Ligand and Interferon-γ May Be Involved in Ulcerogenesis in Patients with Helicobacter pylori -positive Gastric Ulcer. Scandinavian Journal of Gastroenterology. 37(5). 501–511. 18 indexed citations
10.
Ina, Kenji, Kazuo Kusugami, Masaaki Shimada, et al.. (2002). Suppressive Effects of Cyclosporine A on Neutrophils and T Cells May Be Related to Therapeutic Benefits in Patients with Steroid-Resistant Ulcerative Colitis. Inflammatory Bowel Diseases. 8(1). 1–9. 22 indexed citations
11.
Iwase, Hiroaki, Osamu Maeda, Masaaki Shimada, et al.. (2001). Endoscopic ablation with cyanoacrylate glue for isolated gastric variceal bleeding. Gastrointestinal Endoscopy. 53(6). 585–592. 65 indexed citations
12.
Imada, Akira, Kenji Ina, Muneaki Shimada, et al.. (2001). Coordinate Upregulation of Interleukin-8 and Growth-Related Gene Product-α is Present in the Colonic Mucosa of Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology. 36(8). 854–864. 38 indexed citations
13.
Ohsuga, Masahiro, Kazuo Kusugami, Kenji Ina, et al.. (2000). Comparison between in vivo and in vitro chemokine production in Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 14(s1). 205–215. 13 indexed citations
14.
Ina, Kenji, Kazuo Kusugami, Takehiko Hosokawa, et al.. (1999). Increased mucosal production of granulocyte colony‐stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease. Journal of Gastroenterology and Hepatology. 14(1). 46–53. 70 indexed citations
15.
Ando, Takafumi, Kazuo Kusugami, Masahiro Ohsuga, et al.. (1998). Mucosal Macrophage Inflammatory Protein-1α Levels Are Increased in Helicobacter pylori Infection. Journal of Clinical Gastroenterology. 27. S144–S149. 11 indexed citations
16.
Ina, Kenji, Kazuo Kusugami, Takeo Yamaguchi, et al.. (1997). Mucosal interleukin-8 is involved in neutrophil migration and binding to extracellular matrix in inflammatory bowel disease.. PubMed. 92(8). 1342–6. 96 indexed citations
17.
Kusugami, Kazuo, Takafumi Ando, Masahiro Ohsuga, et al.. (1997). Mucosal Chemokine Activity inHelicobacter pylori Infection. Journal of Clinical Gastroenterology. 25. S203–S210. 39 indexed citations
18.
Kusugami, Kazuo, Toshihiro Matsuura, Kenji Ina, et al.. (1990). Interleukin 2 and interferon-γ activities of mononuclear cells from regional lymph nodes in patients with gastric cancer. Gastroenterologia Japonica. 25(3). 306–313. 2 indexed citations
19.
Usami, Yoshiko, et al.. (1987). Metabolism of fluoropyrimidines in cancer patients (Part II).. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 18(4). 689–697. 3 indexed citations
20.
Horiuchi, Tadashi, S Suga, Hideo Sawada, et al.. (1985). Basic study for the clinical application of fluoropyrimidines to cancer chemotherapy. Part I. Metabolism of fluoropyrimidines in cancer patients.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 16(3). 475–487. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026